We therefore have established a more pathophysiologically relevant prostate carcinogenesis model by knocking-in of human SKP2 gene into a locus that is regulated by the endogenous probasin promoter using the CRISPR/Cas9 method. Here, SKP2 is linked to urogenital neoplasm.